/
We operate and report using a 52-53 week fiscal year ending on the last Sunday in September. Our 52-week fiscal years consist of four equal fiscal quarters of 13 weeks each, and our 53-week fiscal years consist of three 13-week fiscal quarters and one 14-week fiscal quarter.
$228.99
$22.03 (-8.78%)
Price from 2 days ago
Margins and capital returns are both well above average: 27.90% operating margin, ROIC at 24.85%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Revenue up 13.7% YoY with margins expanding 2.1pp.
At 25x earnings, the current multiple leaves limited room for execution misses or growth deceleration.
25.3x earnings, 23.5x FCF. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$43.21B
▲ +13.7% YoY
Net Income (TTM)
$9.73B
▼ -45.4% YoY
Op. Margin
25.71%
▲ +2.1pp YoY
ROIC
23.40%
Cash Flow & Balance Sheet
FCF (TTM)
$10.43B
▲ +14.9% YoY
Op. Cash Flow (TTM)
$11.87B
▲ +14.8% YoY
Net Debt
$5.47B
Cash & Equiv.
$9.80B
5Y CAGR: +13.5%
5Y CAGR: +23.8%
Continue Research